SEC Form 4 · accession 0001179110-15-015240
OSIRIS THERAPEUTICS, INC. · OSIR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lode Debrabandere
Officer — President & CEO
Period of report
Nov 20, 2015
Accepted (ET)
Nov 20, 2015 · 5:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001360886
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2015 | M | 37,500 | $6.84 | A | 37,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $6.84 | Nov 20, 2015 | M | 37,500 | D | Jul 31, 2007 | Jul 31, 2016 | Common Stock | 37,500 | 410,000 | D |